Amlodipine Besylate/Losartan Potassium

苯磺酸氨氯地平/氯沙坦钾

Report date: 2026/05/28 20:00:21

Base Information

Drug NameAmlodipine Besylate/Losartan Potassium
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsVoltage-gated calcium channelAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertensionMyopia
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryEU
Original Approved Date2014/01/06
Country/TerritoryUnited StatesNetherlandsHungary +[8] 
CombinationsYes Amlodipine BesylateLosartan Potassium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKrka, D. D., Novo Mesto
China Registration ClassN/A

Develop Information

Active CompaniesKrka, D. D., Novo MestoVyluma IncBeijing Hanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionMyopia
Inactive IndicationsN/A

Other Information

ATC CodeC09DB06
Related LinksN/A